Microneedles

Microneedle array patches (MAPs) represent a groundbreaking pharmaceutical innovation, offering a more efficient way to deliver active pharmaceutical ingredients (APIs) directly beneath the skin. This technology is already being used to treat conditions like migraines more quickly and can simplify the storage and administration of vaccines. At Harro Höfliger, we are at the forefront of developing these advanced devices, leveraging our expertise and resources to design the complex production processes. We are also preparing for large-scale serial production during the early stages of development, ensuring that this promising technology can be widely accessible in the near future.

Microneedle systems operate on the same fundamental principle: the tiny needles penetrate the outer skin layer to deliver active pharmaceutical ingredients (APIs) directly into the dermis or bloodstream. Different approaches are being explored by development teams and research institutions to optimize API delivery. Coated microneedles allow the API to dissolve in the skin, while hollow microneedles (HM) are ideal for administering higher doses. Additionally, some needles embed the API in a soluble matrix, which fully dissolves after application. This modular technology enables tailored solutions for various therapeutic needs.